Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-17

FDA Approved: LATANOPROST OPHTHALMIC SOLUTION — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved an original application for latanoprost ophthalmic solution from Lifestar Pharma LLC, providing a generic version of latanoprost.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost Ophthalmic Solution (latanoprost)

Snippet

ORIG AP for LATANOPROST OPHTHALMIC SOLUTION (LATANOPROST OPHTHALMIC SOLUTION)